Trial Profile
A Phase I, Randomized, Open-Label, Active- and Placebo-Controlled Parallel Group Study of the Effect of Subcutaneous and Intravenous Methylnaltrexone on CYP450 2D6 Activity in Healthy Extensive Metabolizers of Dextromethorphan.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 May 2019
Price :
$35
*
At a glance
- Drugs Methylnaltrexone bromide (Primary) ; Methylnaltrexone bromide (Primary) ; Paroxetine
- Indications Constipation
- Focus Pharmacokinetics
- Sponsors Progenics Pharmaceuticals
- 17 Jul 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 09 Jun 2011 New trial record